CD34 and neoplasm: To elucidate the potential mechanisms involved in tumor growth inhibition by TFAP2BshRNA in vivo, we also analyzed the expression of VEGF, PEDF and micro-vessel density marker CD34 in tumors by immunohistochemical staining and found that VEGF expression was inhibited and the mean MVD was reduced (Figure 6E).